Radiation | Jotup

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Retrieved on:

Tuesday, March 26, 2024

Radiation, Prostate cancer, Disease, Incidence, Patient, Rectum, RSS, Prostate, Motion, SBRT, Quality of life, Cyberknife, MBA, Neoplasm, Accuray, Movement, Health, Medical imaging

MADISON, Wis., March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois support the use of the CyberKnife® System in the treatment of high-risk and recurrent prostate cancer. The studies expand on years of published clinical follow-up with a large number of prostate cancer patients with various stages of disease, as well as with those who were previously treated with radiotherapy – supporting the system's versatility and value to medical care teams.

Key Points:

"An extensive number of peer-reviewed scientific manuscripts have been published reporting on CyberKnife prostate SBRT efficacy and tolerability.
The system's precision enables clinicians to confidently treat the prostate gland, which is situated near the sensitive bladder and rectum, with SBRT.
Provide a viable option with "a low incidence of short-term genitourinary (GU) and gastrointestinal (GI) toxicities" for reirradiation of locally recurrent prostate cancer2.
For example, if the prostate moves during treatment the CyberKnife® System detects this movement and synchronizes the treatment delivery beam to the tumor's new position in real-time.

PathKeeper Surgical enters into know-how agreement with Mayo Clinic for low-radiation pediatric spine surgery

Retrieved on:

Monday, March 25, 2024

MD, Radiation, Deformity, Machine learning, Mayo Clinic, KFAR, Research, Patient, Surgeon, Standard of care, Scoliosis, Safety, Dentistry

KFAR SABA, Israel, March 25, 2024 /PRNewswire/ -- PathKeeper Surgical, an Israeli medical technology company committed to advancing surgical solutions through innovative camera and machine learning technologies, announced it has entered into a know-how agreement with Mayo Clinic to research radiation levels in pediatric spine surgeries. The research will focus on reducing patient radiation exposure using minimally invasive optical navigation and utilizing intraoperative measurement tools for scoliosis correction, including vertebral body tethering.

Key Points:

PathKeeper Surgical enters a know-how agreement with Mayo Clinic in Rochester, MN.
To address the unique challenges of pediatric patients undergoing spine surgery for scoliosis, Mayo Clinic pediatric spine surgeons Noelle Larson, MD, and Todd Milbrandt, MD, are collaborating with PathKeeper Surgical, a company widely known for its cutting-edge optical navigation that prioritize precision, safety, and minimization of radiation exposure.
"We are proud to collaborate with Mayo Clinic," said Erez Lampert, founder and Chief Executive Officer at PathKeeper Surgical.
The research and development efforts will include refining and expanding the application of PathKeeper's technology to tackle the unique challenges posed by pediatric spine surgery.

Free Online Summit to Reveal Common Toxins Found in Homes and Ways to Reduce Them April 22-28, 2024

Retrieved on:

Monday, March 25, 2024

WHITEHOUSE STATION, N.J., March 25, 2024 /PRNewswire-PRWeb/ -- We often think that nutrition, exercise, and a healthy lifestyle are the keys to wellness. But what if our internal home environment also greatly affects our longevity and health more than we realize?

Key Points:

But what if our internal home environment also greatly affects our longevity and health more than we realize?
"Homes that are not properly maintained and cleaned for toxins can lead to a plethora of problems that contribute to health issues.
Fortunately, changes to your living and working environment can provide you with the opportunity to improve your health and prevent disease."
Join the experts April 22-28, 2024, to discover how to create a home for you and your family that fosters health and promotes a healthier planet!

Cryoablation Highly Effective for Breast Cancer Patients with Large Tumors

Retrieved on:

Saturday, March 23, 2024

Radiation, Breast cancer, Patient, Neoplasm, Research, Breast, Cancer, Society, Freezing, Woman, Cryoablation, Ice, Recurrence, Hypertension, Medical imaging

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumors has now been proven effective for breast cancer patients with large tumors, providing a new treatment path for those who are not candidates for surgery, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points:

"For patients who have larger tumors but can't undergo surgery, this approach could be more effective than the current standard of care for patients who are not surgical candidates," said Yolanda Bryce, M.D., an interventional radiologist at Memorial Sloan Kettering Cancer Center.
Cryoablation is a minimally invasive treatment that uses imaging guidance such as ultrasound or a computed tomography (CT) scan to locate tumors.
If the tumors do grow, patients can be treated with cryoablation multiple times to control growth.
Patients with tumors larger than 1.4 cm were treated with multiple probes (one probe placement for each centimeter of disease).

New treatment option for prostate cancer shows successful outcomes

Retrieved on:

Saturday, March 23, 2024

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points:

"Prostate cancer is the most common form of cancer in men, affecting one in eight men in their lifetimes.
According to Dr. Raman, "This image-guided therapy maximizes our ability to kill cancer cells while minimizing collateral damage to the prostate to achieve the ultimate trifecta in prostate cancer treatment: full local cancer control while maintaining urinary continence and potency.
The latter are the complications of most prostate cancer therapies that patients hate and often result from a lack of precision in treatment monitoring."
Abstract #135 : Five-year outcomes after MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer.

XPlan.ai Confirms Premier Precision in Peer-Reviewed Clinical Study of its 2D-to-3D Knee Reconstruction Solution

Retrieved on:

Thursday, March 21, 2024

Diagnosis, Elective surgery, Radiation, X-ray, Infection, Medicine, Patient, Anatomy, Journal, Artificial intelligence, 3D, Assuta Medical Center, Surgeon, Robotics, Journal of Clinical Medicine, Medical director, FDA, TEL, Medical imaging

TEL AVIV, Israel, March 21, 2024 /PRNewswire/ -- XPlan.ai, a spinoff of RSIP Vision that uses AI to democratize precision orthopedics, reaches a new milestone for its X-ray based 3D bone modeling system with the publication of a peer-reviewed clinical study confirming unprecedented, sub-mm accuracy in a variety of clinically relevant measurements. The study, led by a consortium of orthopedic surgeons and published in the Journal of Clinical Medicine, found that XPlan.ai offers a promising alternative to conventional CT scans, opening up the market for image-based computer-assisted surgery such as robotics, AR, and navigation while increasing efficiency, saving costs and avoiding unnecessary radiation exposure.

Key Points:

XPlan.ai uses advanced artificial intelligence (AI) to produce accurate 3-dimensional bone models from two standard X-ray images.
The clinical benefit is lower levels of radiation exposure from X-ray imaging compared to a complete knee CT scan.
I am encouraged to see that the accuracy of XPlan's solution has passed the most stringent tests conducted in our study."
Going forward, XPlan.ai plans to apply for FDA clearance of its knee reconstruction solution.

Space Semiconductor Market to Reach $4,813.8 million, Globally, by 2032 at 8.8% CAGR: Allied Market Research

Retrieved on:

Tuesday, March 19, 2024

WILMINGTON, Del., March 19, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Space Semiconductor Market by Type (Radiation Hardened Grade and Radiation Tolerant Grade), Component (Integrated Circuits, Discrete Semiconductors Devices, Optical Devices, Microprocessor, Memory, Sensors, and Others), and Application (Satellite, Launch Vehicles, Deep Space Probe, and Rover and Lander): Global Opportunity Analysis and Industry Forecast, 2023–2032.

Key Points:

In addition, large amounts of certain semiconductor materials, like neon gas, are made in Ukraine and are used in the semiconductor manufacturing process.
Recent Advancements in the Space Semiconductor Sector Showcase Notable Collaborations and Innovations:
In August 2021, BAE Systems joined forces with Global Foundries to fabricate a radiation-hardened single-board computer tailored for space applications.
In September 2023, Northrop Grumman's U.K. division partnered with British startup Space Forge, which endeavors to manufacture semiconductors in space.
On the basis of component, the integrated circuits segment held the highest market share in 2022, accounting for around one-third of the global space semiconductor market revenue.

Space Semiconductor Market to Reach $4,813.8 million, Globally, by 2032 at 8.8% CAGR: Allied Market Research

Retrieved on:

Tuesday, March 19, 2024

WILMINGTON, Del., March 19, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Space Semiconductor Market by Type (Radiation Hardened Grade and Radiation Tolerant Grade), Component (Integrated Circuits, Discrete Semiconductors Devices, Optical Devices, Microprocessor, Memory, Sensors, and Others), and Application (Satellite, Launch Vehicles, Deep Space Probe, and Rover and Lander): Global Opportunity Analysis and Industry Forecast, 2023–2032.

Key Points:

In addition, large amounts of certain semiconductor materials, like neon gas, are made in Ukraine and are used in the semiconductor manufacturing process.
Recent Advancements in the Space Semiconductor Sector Showcase Notable Collaborations and Innovations:
In August 2021, BAE Systems joined forces with Global Foundries to fabricate a radiation-hardened single-board computer tailored for space applications.
In September 2023, Northrop Grumman's U.K. division partnered with British startup Space Forge, which endeavors to manufacture semiconductors in space.
On the basis of component, the integrated circuits segment held the highest market share in 2022, accounting for around one-third of the global space semiconductor market revenue.

QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy

Retrieved on:

Monday, March 18, 2024

Radiation, CE, ASX, European, TLX, FDA, Nuclear medicine, Medical imaging

QDOSE® is a validated, versatile software platform that enables reliable estimation of patient-specific dosimetry for both therapeutic and diagnostic radiopharmaceuticals.

Key Points:

QDOSE® is a validated, versatile software platform that enables reliable estimation of patient-specific dosimetry for both therapeutic and diagnostic radiopharmaceuticals.
Telix intends to integrate the QDOSE® platform into its therapeutic radiopharmaceutical programs and clinical collaborations to enable the development of personalised treatment regimens.
Personalised radiopharmaceutical therapy administration based on individual patient dosimetry has the potential to improve clinical outcomes by optimising treatment response while reducing effects on normal healthy organs and optimising the use of isotope supply chains.
Rapid, reliable and personalised dosimetry is becoming an increasingly important future direction of cancer care and regulatory authorities now expect to see dosimetry analysis.

Blue Ridge Environmental Defense League: Rising death rates in Burke County, GA after startup of the Alvin Vogtle Nuclear Plant

Retrieved on:

Monday, March 18, 2024

Void coefficient, Social justice, RPHP, Mortality, Cancer, Death, Southern Company, Justice, Georgia Power, Radiation, Uranium mining

WAYNESBORO, Ga., March 18, 2024 /PRNewswire/ -- Today an expert study of local death rates and cancer was released to the public at a meeting in Waynesboro, Georgia, the site of four nuclear power stations operated by Southern Company and Georgia Power.

Key Points:

The study revealed that the death rate in Burke County, GA, which was 19% above the U.S. death rate before Vogtle 1 and 2 nuclear reactors began operation in the late 1980s, has since increased to 35% above the U.S. death rate.
Death rates increased for both Black and Caucasian residents of Burke County and were largest for young and old residents.
"Since the late 1980s, dramatic increases have occurred in Burke County death rates," said Joseph Mangano MPH MBA.
The creation of RPHP's report was funded by a grant to Blue Ridge Environmental Defense League (BREDL) from Center for Health, Environment, and Justice (CHEJ).